Clinical Trial: Abatacept Treatment in Polymyositis and Dermatomyositis
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Abatacept Treatment in Polymyositis and Dermatomyositis
Brief Summary: The purpose of this study is to investigate the clinical efficacy of abatacept on disease activity in polymyositis, and dermatomyositis patients.
Detailed Summary: Patients with polymyositis or dermatomyositis who have persisting signs of inflammatory active disease after treatment with glucocorticoids and at least one immunomodulating drug (e.g. methotrexate or azathioprine) for a minimum of 3 months.
Sponsor: Karolinska Institutet
Current Primary Outcome: The number of responders, defined as improved according the IMACS criteria [ Time Frame: 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: The change in the individual components of the IMACS core set measures for disease activity [ Time Frame: at 3 and 6 months ]
Original Secondary Outcome: Same as current
Information By: Karolinska Institutet
Dates:
Date Received: March 15, 2011
Date Started: January 2011
Date Completion: June 2013
Last Updated: March 15, 2011
Last Verified: February 2010